第一医药
(600833)
| 流通市值：23.38亿 | | | 总市值：23.38亿 |
| 流通股本：2.23亿 | | | 总股本：2.23亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 981,570,843.53 | 484,557,342.69 | 2,130,234,461.61 | 1,539,077,117.96 |
| 营业总成本 | 985,353,464.67 | 484,521,297.47 | 2,128,144,034.15 | 1,536,044,900.73 |
| 其他经营收益 | | | | |
| 营业利润 | 33,420,882.62 | 31,288,843.89 | 74,742,727.7 | 63,455,424.94 |
| 利润总额 | 34,002,912.19 | 30,957,297.32 | 76,046,088.16 | 70,118,313.89 |
| 净利润 | 26,491,984.88 | 23,660,776.51 | 58,536,397.11 | 54,020,386.58 |
| 每股收益 | | | | |
| 其他综合收益 | -49,379,525.7 | -2,915,731.79 | 17,005,779.85 | 20,954,541.38 |
| 综合收益总额 | -22,887,540.82 | 20,745,044.72 | 75,542,176.96 | 74,974,927.96 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,047,671,747.9 | 1,041,740,436.78 | 1,057,025,185.35 | 1,199,552,267.19 |
| 非流动资产: | | | | |
| 非流动资产合计 | 851,554,721.31 | 949,279,499.59 | 964,299,127.52 | 831,141,725.82 |
| 资产总计 | 1,899,226,469.21 | 1,991,019,936.37 | 2,021,324,312.87 | 2,030,693,993.01 |
| 流动负债: | | | | |
| 流动负债合计 | 626,052,127.85 | 615,223,974.93 | 666,492,450.33 | 703,299,799.44 |
| 非流动负债: | | | | |
| 非流动负债合计 | 142,601,205.87 | 184,189,505.34 | 183,970,451.16 | 157,100,031.19 |
| 负债合计 | 768,653,333.72 | 799,413,480.27 | 850,462,901.49 | 860,399,830.63 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,120,675,185.62 | 1,181,632,520.09 | 1,161,285,666.1 | 1,160,757,026.08 |
| 股东权益合计 | 1,130,573,135.49 | 1,191,606,456.1 | 1,170,861,411.38 | 1,170,294,162.38 |
| 负债和股东权益合计 | 1,899,226,469.21 | 1,991,019,936.37 | 2,021,324,312.87 | 2,030,693,993.01 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,070,124,413.64 | 524,004,618.93 | 2,369,327,251.14 | 1,688,862,303.81 |
| 经营活动现金流出小计 | 1,048,752,152.41 | 515,655,525.85 | 2,280,446,747.3 | 1,664,320,682.29 |
| 经营活动产生的现金流量净额 | 21,372,261.23 | 8,349,093.08 | 88,880,503.84 | 24,541,621.52 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 172,294,073.83 | 96,874,608.12 | 413,174,382.16 | 334,342,533.79 |
| 投资活动现金流出小计 | 92,937,002.93 | 31,564,174.15 | 448,952,791.19 | 327,489,546.09 |
| 投资活动产生的现金流量净额 | 79,357,070.9 | 65,310,433.97 | -35,778,409.03 | 6,852,987.7 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 99,289,263.89 | 99,289,263.89 |
| 筹资活动现金流出小计 | 93,676,730.07 | 62,678,239.49 | 257,464,246.6 | 190,377,229.39 |
| 筹资活动产生的现金流量净额 | -93,676,730.07 | -62,678,239.49 | -158,174,982.71 | -91,087,965.5 |
| 汇率变动对现金及现金等价物的影响 | -488,502.8 | -93,397.69 | -1,272,724.99 | -560,726.39 |
| 现金及现金等价物净增加额 | 6,564,099.26 | 10,887,889.87 | -106,345,612.89 | -60,254,082.67 |
| 期末现金及现金等价物余额 | 329,088,494.29 | 333,112,587.35 | 322,524,395.03 | 368,615,925.25 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 6,564,099.26 | - | -106,345,612.89 | - |